Ocugen Inc (NASDAQ: OCGN) closed the day trading at $0.98 up 4.43% from the previous closing price of $0.94. In other words, the price has increased by $+0.0417 from its previous closing price. On the day, 3372050 shares were traded.
Ratios:
For a better understanding of OCGN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.08 and its Current Ratio is at 5.08. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.08.
On August 23, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $5.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 14 ’23 when Zhang Junge bought 200,278 shares for $0.50 per share. The transaction valued at 99,999 led to the insider holds 1,077,182 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OCGN now has a Market Capitalization of 252.40M and an Enterprise Value of 205.40M.
Stock Price History:
Over the past 52 weeks, OCGN has reached a high of $1.28, while it has fallen to a 52-week low of $0.34. The 50-Day Moving Average of the stock is 0.7046, while the 200-Day Moving Average is calculated to be 0.5171.
Shares Statistics:
Over the past 3-months, OCGN traded about 5.73M shares per day on average, while over the past 10 days, OCGN traded about 4.78M shares per day. A total of 256.50M shares are outstanding, with a floating share count of 250.87M. Insiders hold about 2.20% of the company’s shares, while institutions hold 10.22% stake in the company. Shares short for OCGN as of Feb 29, 2024 were 36.65M with a Short Ratio of 6.40, compared to 23.71M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 14.29% and a Short% of Float of 18.53%.
Earnings Estimates
Current recommendations for the stock of the company come from 2 analysts. On average, analysts expect EPS of -$0.06 for the current quarter, with a high estimate of -$0.06 and a low estimate of -$0.07, while EPS last year was -$0.1. The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.06 and low estimates of -$0.07.
Analysts are recommending an EPS of between -$0.28 and -$0.29 for the fiscal current year, implying an average EPS of -$0.28. EPS for the following year is -$0.28, with 2 analysts recommending between -$0.25 and -$0.31.
